BPLPHARMA Quarterly Results, Profit & Loss, Balance Sheet (BPLPHARMA)

BPLPHARMA quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • BPLPHARMA Financials
  • BPLPHARMA Shareholding Pattern
  • BPLPHARMA Earnings Documents
  • BPLPHARMA Announcements
  • BPLPHARMA Corporate Actions
  • BPLPHARMA Bulk, Block & Insider Deals
  • BPLPHARMA Delivery Data
  • BPLPHARMA Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Bharat Parenterals Ltd (BPLPHARMA) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Bharat Parenterals Ltd reported sales of ₹136 Cr, operating profit of ₹24 Cr (OPM 17%) and net profit of ₹12 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

BPLPHARMA quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales72104116656510094136
Expenses69102102646310085113
Operating Profit421412-1924
OPM5%2.1%12%1.3%2.7%-0.5%9%17%
Other Income32141413
Interest34433323
Depreciation99998999
Profit before tax-6-83-7-8-8-214
Tax43%14%134%18%17%-3%138%16%
Net Profit-8-9-1-9-10-8-412
EPS in Rs-2.42-6.8611.94-10.5-6.37-6.961.4713.67
BPLPHARMA profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales212218261340345395
Expenses183198234337330362
Operating Profit29202741633
OPM14%9%10%1.1%4.6%8%
Other Income712511109
Interest134131311
Depreciation769353435
Profit before tax282419-34-21-4
Tax25%33%44%29%27%-
Net Profit211611-44-27-10
EPS in Rs36.4528.4724.95-18.33-11.881.81
Dividend Payout0%3%4%-5%-8%-
BPLPHARMA balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital67-77
Reserves191324-315325
Borrowings158180-146160
Other Liabilities149138-145171
Total Liabilities504649-613664
Fixed Assets211252-255245
CWIP2531-3536
Investments05-662
Other Assets268360-317320
Total Assets504649-613664
BPLPHARMA cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-122-5-2738
Cash from Investing Activity-7-78-105-1379
Cash from Financing Activity961110156-47
Net Cash Flow241-81
Free Cash Flow-40-68-108-56-1
CFO/OP16%150%18%-444%305%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit1615018-444305
BPLPHARMA ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days126188198184159
Inventory Days56100142132162
Days Payable64136137136122
Cash Conversion Cycle118152202180199
Working Capital Days148918176143
ROCE17%11%7%-4%-2%
  • BPLPHARMA Shareholding Pattern
  • BPLPHARMA Earnings Concalls
  • BPLPHARMA Growth Catalysts
  • BPLPHARMA Corporate Actions
  • BPLPHARMA Announcements
  • BPLPHARMA Results & Documents
  • BPLPHARMA Bulk & Block Deals
  • BPLPHARMA Delivery Data